檢索結果 - Phil‐Robin Tepasse
- Showing 1 - 11 results of 11
-
1
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1) 由 Martin Dugas, Tanja Grote-Westrick, Richard Vollenberg, Eva U. Lorentzen, Tobias Brix, Hartmut Schmidt, Phil‐Robin Tepasse, Joachim Kühn
出版 2021Artigo -
2
-
3
-
4
-
5
Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature 由 Phil‐Robin Tepasse, Wali Hafezi, Mathias Lutz, Joachim Kühn, Christian Wilms, Rainer Wiewrodt, Jan Sackarnd, Martin S. Keller, Hartmut Schmidt, Richard Vollenberg
出版 2020Revisão -
6
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19 由 Philipp Jörrißen, Paula Schütz, Matthias Weiand, Richard Vollenberg, Inga Marie Schrempf, Kevin Ochs, Christopher Frömmel, Phil‐Robin Tepasse, Hartmut Schmidt, Andree Zibert
出版 2021Artigo -
7
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2 由 Richard Vollenberg, Phil‐Robin Tepasse, Joachim Kühn, Marc Tim Hennies, Markus Strauß, Florian Rennebaum, Tina Schomacher, Göran Ramin Boeckel, Eva U. Lorentzen, Arne Bokemeyer, Tobias M. Nowacki
出版 2022Artigo -
8
-
9
Discrimination of COVID‐19 From Inflammation‐Induced Cytokine Storm Syndromes Using Disease‐Related Blood Biomarkers 由 Christoph Kessel, Richard Vollenberg, Katja Masjosthusmann, Claas Hinze, Helmut Wittkowski, France Debaugnies, Carole Nagant, Francis Corazza, Frédéric Vely, Gilles Kaplanski, Charlotte Girard, Cem Gabay, Hartmut Schmidt, Dirk Foell, Phil‐Robin Tepasse
出版 2021Artigo -
10
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19 由 Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaëla Fontenay, Andreas E. Kremer, Frank Hanses, Richard Vollenberg, Eva U. Lorentzen, Shilpa Tiwari‐Heckler, Jérôme Duchemin, Syrine Ellouze, Marcel Vetter, Julia Fürst, Philipp Schuster, Tobias Brix, Claudia M. Denkinger, Carsten Müller‐Tidow, Hartmut Schmidt, Phil‐Robin Tepasse, Joachim Kühn
出版 2021Artigo -
11
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial 由 Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus A. Weigand, Christian Nußhag, Lars Bullinger, Jens Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria J. G. T. Vehreschild, Stefan Schmiedel, Marylyn M. Addo, Felix J.F. Herth, Michael Kreuter, Phil‐Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl Christoph Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried V. Kern, Anita Schmitt, Hanns‐Martin Lorenz, Margarida Souto‐Carneiro, Mary Gaeddert, Niels Halama, Stefan Meuer, Hans‐Georg Kräusslich, Bárbara Müller, Paul Schnitzler, Sylvia Parthé, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Michael Schmitt, Peter Dreger, Katharina Kriegsmann, Richard F. Schlenk, Carsten Müller‐Tidow
出版 2022Artigo
相關主題
Medicine
Immunology
Internal medicine
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Antibody
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Gastroenterology
2019-20 coronavirus outbreak
ARDS
Biochemistry
Biology
Cohort
Coronavirus
Endothelial dysfunction
Glycocalyx
Inflammation
Lung
Outbreak
Pathology
Prospective cohort study
Severity of illness
Acute-phase protein
Adverse effect
Anosmia
Biomarker
Cancer
Chemistry